Strategies to Reduce the Onset of Sleeve Gastrectomy Associated Bone Loss (STRONG BONES)
Awarding Agency: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Funding Source: National Institutes of Health (NIH)
Principal Investigator(s): Kristen M. Beavers, PhD;
Jamy D. Ard, MD
Co-investigators: Adolfo Fernandez, MD; Daniel Beavers, PhD; Ashley Weaver, PhD; Jamie Justice, PhD
About STRONG BONES:
Participants in the STRONG BONES study are 40 years of age and older and scheduled to undergo a sleeve gastrectomy through the Wake Forest Weight Management Center. Patients will be randomized to receive either the study drug, Risedronate, or a placebo for six months. Changes in bone density with post-surgical weight loss will be measured and compared.
You may qualify to participate if you are:
* Scheduled for a sleeve gastrectomy through Wake Forest Weight Management Center
* 40 years of age or older
Complete this brief survey to see if you may qualify to participate!
To learn more about the study, please call (336) 758-4078 or email email@example.com.